Abstrak
Congenital absence of the portal vein (CAPV) is a rare congenital malformation in which the intestinal and splenic venous drainage bypasses the liver and drains into inferior vena cava, renal vein or iliac vein through a congenital portosystemic shunt. [1] [2] [3] The first case of this malformation was reported by Abernethy in 1793 and the last one was documented by Appel et al. in 2003 . Only twenty seven cases of CAPV has been reported within that period of time. 3, 4 We report one case of CAPV in a 32-year-old woman with splenomegaly and hypersplenism but with no liver nor cardiac anomalies in which she suffered hematemesis and melena repetitively since the age of 4-year-old.
Case Report
A 32-year-old woman admitted to the hospital due to hematemesis and melena. She had the first episode of it on the age of 4-year-old and experienced it again on the age of 14 and 24-year-old. She was admitted to the hospital and had blood transfusion at that moment. Three years ago another episode happened, she was hospitalized and was suspected of suffering liver cirrhosis. She underwent endoscopic injection sclerotherapy 4 times and was suggested to undergo this therapy once in a year but she never done it because of afraid of the procedure. There is no history of alcoholism. She never experienced jaundice, intestinal distention, enlargement of abdomen, swelling of the lower extremity, vomiting, nausea and encephalopathy or lost of consciousness. There is no weight loss and stool discolorization.
On physical examination there is no sign of jaundice nor ascites. The liver is not enlarged but the spleen was enlarged and can be palpated on Schuffner 3.
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Laboratory test showed pancytopenia (Hemoglobin 10,3g/dl, leucocyte 3.900/l, thrombocyte 118.000/l) and liver function test within normal limits (albumin 4,6g/dl, globulin 2,6g/dl, direct bilirubin 0,2mg/dl, indirect bilirubin 0,4mg/dl). Transaminases, alkaline phosphatase and GT was normal (SGOT 18U/l, SGPT 7U/l, Alkaline phosphatase 121U/l, and GT 15U/l). Haemostatic test showed chronic DIC (PT 12,1s; control 11,8s; APTT 25,8s; control 28,1s; fibrinogen 244mg/dl and D Dimer 600ng/ml).
Endoscopic examination was performed but injection sclerotherapy could not be done because it could generate bleeding so we planned to do splenectomy. MRI of the abdomen revealed no focal lession in the liver and the biliary system intra and extra hepatic was normal. The spleen was enlarged with homogenous density. Gall bladder, pancreas, kidney and aorta were normal. MRI abdomen concluded splenomegaly and fatty liver ( Figure 1 ). fig. 2 and 3 ).
Based on the angiography the diagnosis of CAPV was made. We performed laparotomy and found enlargement of the spleen with no abnormality on the liver. Veins around the stomach were dilated. Splenectomy was done due to hypersplenism.
Histopathology examination of the spleen showed congestion and enlargement of the red pulp, resembled hypersplenism and no sign of malignancy. The patient was discharge 5 days after surgery in good condition.
Six months after the operation patient had no complaints and endoscopy was performed to evaluate the esophageal and gastric varices. The esophageal varices had disappear and the size of gastric varices had decrease. 
DISCUSSION
Embryologically, the portal vein formed in the 5-10 weeks of gestation, it derives from selective involution and the persistence of the vitelline venous system. [1] [2] [3] 5 Abnormal patterns of involution and persistence may result in a preduodenal, prebiliary or duplicated portal vein, and excessive involution may result in absence of the portal vein. 2, 5 The complex development of the vena cava and its close relation to development of the vitelline veins likely explain the occurrence of the rare congenital extrahepatic portosystemic anastomoses. 2 Congenital absence of the portal vein was first reported by Abernethy in 1793. 3, 7, 11 Morgan and Superina in 1994 proposed a classification of portosystemic anomalies (Table 1) . 1 There is a clear clinical distinction between patients with the type I and type II shunts. In type I shunts, the patients are typically young at the time of presentation.
There usually is little encephalopathy, despite the pressence of high ammonemia levels. Often there are other anomalies including cardiac malformations and hepatic tumors. In the type II shunt, which is most often acquired, the patients typically present at middle or late-middle age. The initial symptoms often are encephalopathy with a high serum amonia level of unknown cause and a vascular anomaly, which is discovered after various investigations. [1] [2] [3] 6, 7 Type II shunt are often secondary to cirrhosis, but congenital shunts have been reported. 1, 8, 9 The CAPV in our patient was a type I shunt but the subtype can not be defined because the presence of confluence of the superior mesenteric vein and splenic vein can not be determined during angiography.
CAPV predominantly found in female and in 24 cases the diagnosis was made before the age of 18-year-old (Tabel 2).
3,10 Cardiac and liver malformations are frequently observed in patients with CAPV. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Typical additional liver diseases are focal nodular hyperplasia, hepatocellular adenoma, hepatocellular carcinoma and biliary atresia. Cardiac anomalies that may occur are patent ductal arteriosus, patent foramen ovale, ventricular septum defect and atrial septum defect. 4, 6, 10, 11 Our patient experienced hematemesis and melena for the first time at the age 4-year-old. Since then the symptom repeated but she never had encephalopathy nor lost of consciousness. Encephalopathy rarely occurred in CAPV, only 2 CAPV cases with portosystemic encephalopathy were reported, 12,13 and 1 patient with subclinical encephalopathy had mild tremor as the symptom. 14 Liver chemistry may be slightly altered in cases of CAPV as reported in some literatures, but in our case the liver function test and transaminases are within normal range. This is similar with the report from Laverdiere et al. 15 Our patient with a history of variceal bleeding was suspected of suffering hepatic cirrhosis, but the laboratory findings and abdominal MRI unlikely support that diagnosis. The condition of noncirrhotic portal hypertension with the possibility of anomaly of the portal vein were the probable cause of that symptom. We performed angiography to evaluate the vessel and confirm the diagnosis. Hepatic angiography and indirect portography could not identify the pressence of the extra hepatic nor the intra hepatic portal vein, the systemic shunt could not be identified either.
In most previous cases, a common trunk formed by the joined superior mesenteric vein and splenic vein draining directly into the inferior vena cava was the most frequent type of systemic shunt 4,11 followed by drainage through the left renal vein. 4 Ultrasonography with echo-color Doppler is usually used as a first method in diagnosing abnormality of portal vein. Though this method can not visualize the portal vein or its main branch, it does show the portocaval shunt as an abnormal pattern on the echocolor Doppler. Further examination can then be planned. CT Scan or MRI can confirm the absence of portal vein and they both can visualize the portosystemic shunt.
2 MR angiography offers the practical advantage of demonstrating the patency and flow direction of the portal vein, and the pressence and extent of the portal venous collaterals in any part of the body. MR angiography has little interference from such body condition as the presence of bowel gas. 5 MR angiography could not be done in our case due to unavailability of the device, thus the drainage site of the superior mesenteric vein and splenic vein could not be confirmed. Based on the history of no encephalopathy nor lost of consciousness due to elevation of the ammonia level in the blood, we hypothesized there could be a drainage system into the caval vein or into intrahepatic vessels.
There is no strict protocol in the treatment of CAPV. The therapy is adjusted according the symptom, the type of congenital systemic shunt and the pressence of other congenital anomaly. Appel et al. reported a case that almost similar like ours, CAPV in a young woman with hypersplenism and splenomegaly but with no hematemesis and melena. In that case the mesenteric blood was drained cranially into the azygos system through extensive paragastric and parasplenic collaterals. Surgical procedure for the splenomegaly was not carry out on that case. 4 In our case, splenectomy was indicated due to hypersplenism and esophageal varices which injection of sclerosing agent could not be done. Thus, the pressure in the veins around the stomach could be decreased and the varix would disappear.
In the future, if the pressure in the mesenteric veins remains high or the number of the collateral not sufficient, there is still a possibility that our patient will suffer variceal bleeding again. On that condition, we must assess the condition of the vessels by MR angiography then planned further treatment. 16 Several studies have recommended major operations for gastric varices such as portosystemic shunt, 17 distal splenorenal shunt18 and esophageal transection. 19, 20 Gastric devascularization and splenectomy can be done for treating esophageal varices. The extent of devascularization included the lower 5 to 10 cm of the esophagus, a lesser curvature to the level of the incisura angularis,and a greater curvature of the stomach to the level adjacent to the incisura angularis. 20 This procedure may also be feasible for gastric varices, because devascularization can directly eradicate blood flow into the gastric wall. 20, 21 The options of surgical procedure that can be performed in our patient if the symptom occur again are shunt surgery such as mesocaval H-graft shunt, coronary-caval shunt (Inokuchi shunt) or gastric devascularization.
Based on the findings in the literature, the shortterm prognosis of patients with CAPV depends on the presence of heart disease in the newborn and the presence of liver disease, whereas the longterm prognosis is controlled by the presence of metabolic disease such as hyperammonemia. 6 There is little information in the literature on the outcome of patients with CAPV, further longterm follow-up is necessary.
